KEMPHARM, INC | Business Contracts

Consulting Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)

Revolving Loan Agreement dated May 31, 2022 by and among KemPharm, Inc. and Ameris Bank, as lender (Filed With SEC on June 1, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2022)

Amendment No. 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA (Filed With SEC on August 13, 2021)

Termination of Agreement of Sublease, by and between KemPharm, Inc. and Ciber Global, LLC, dated as of October 22, 2020 (Filed With SEC on October 30, 2020)

Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)

Amendment to Employment Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Richard W. Pascoe (Filed With SEC on January 9, 2023)

Asset Purchase Agreement by and among KemPharm, Inc., KemPharm Denmark A/S and Orphazyme A/S in restructuring, dated May 15, 2022 (Filed With SEC on May 16, 2022)

Seventh Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 12, 2022)

Executive Employment Agreement by and between the Registrant and Richard W. Pascoe, dated as of November 5, 2021 (Filed With SEC on November 10, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on August 13, 2021)

Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 13, 2021)

Equity Distribution Agreement, dated July 2, 2021, by and among KemPharm, Inc., JMP Securities LLC and RBC Capital Markets, LLC (Filed With SEC on July 2, 2021)

Form of Inducement Letter (Filed With SEC on June 23, 2021)

Form of Inducement Warrant (Filed With SEC on June 23, 2021)

Specimen stock certificate evidencing shares of Common Stock (Filed With SEC on March 12, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2021)

Sixth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2021)

Payoff letter, dated as of February 8, 2021, by and among the Company and the lenders named therein (Filed With SEC on February 9, 2021)

Form of Inducement Letter (Filed With SEC on January 26, 2021)

Form of Inducement Warrant (Filed With SEC on January 26, 2021)

Amendment to Senior Secured Convertible Notes and Amendment to Warrant, dated as of January 12, 2021, by and among the Company, Deerfield Private Design Fund III, L.P. and... (Filed With SEC on January 13, 2021)

Series A Common Stock Purchase Warrant for Underwriter (Filed With SEC on January 13, 2021)

Form of Common Stock Purchase Warrant and schedule of holders (Filed With SEC on January 13, 2021)

Form of Underwriting Agreement (Filed With SEC on January 5, 2021)

Joinder Agreement, dated as of December 23, 2020, by and between KemPharm, Inc. and M. Kingdon Offshore Master Fund, LP (Filed With SEC on December 28, 2020)

Joinder Agreement, dated as of December 23, 2020, by and between KemPharm, Inc. and Delaware Street Capital Master Fund, L.P (Filed With SEC on December 28, 2020)

Amendment to Facility Agreement, Notes and to December 2020 Exchange Agreement, dated as of December 24, 2020, by and among KemPharm, Inc., Deerfield Private Design Fund III, L.P.... (Filed With SEC on December 28, 2020)

Form of Pre-Funded Warrant (Filed With SEC on December 21, 2020)

Form of Common Stock Warrant (Filed With SEC on December 21, 2020)

Form of Underwriting Agreement (Filed With SEC on December 21, 2020)

December 2020 Exchange Agreement and Amendment to Facility Agreement, Notes and Investors Rights Agreement, dated as of December 20, 2020, by and among KemPharm, Inc., Deerfield... (Filed With SEC on December 21, 2020)

Amended and Restated Bylaws of KemPharm, Inc., effective as of July 15, 2020 (Filed With SEC on July 17, 2020)

Fifth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 24, 2020)

Agreement to Sublease, by and between KemPharm, Inc. and Ciber Global, LLC, dated as of January 15, 2020 (Filed With SEC on February 28, 2020)

Registration Rights Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC (incorporated herein by reference to the Registrant's Annual... (Filed With SEC on February 28, 2020)

Amendment to Senior Secured Convertible Notes and Amendment to Warrant, dated as of February 17, 2020, by and among KemPharm, Inc. and the noteholders party thereto (Filed With SEC on February 18, 2020)

Registration Rights Agreement, dated as of February 17, 2020, by and between KemPharm, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)

Purchase Agreement, dated as of February 17, 2020, by and between KemPharm, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)

January 2020 Exchange Agreement, dated as of January 12, 2020, by and between KemPharm, Inc. and M. Kingdon Offshore Master Fund, LP (Filed With SEC on January 13, 2020)

Amendment to December 2019 Notes and Consent, dated as of January 12, 2020, by and among KemPharm, Inc. and the signatories party thereto (Filed With SEC on January 13, 2020)

Senior Secured Convertible Note, dated as of January 13, 2020 (Filed With SEC on January 13, 2020)

Form of Senior Secured Convertible Note, with a schedule of noteholders (Filed With SEC on December 18, 2019)

Amendment to September 2019 Exchange Agreement and Amendment to Facility Agreement, dated as of December 17, 2019, by and among KemPharm, Inc., Deerfield Private Design Fund III,... (Filed With SEC on December 18, 2019)

December 2019 Exchange Agreement and Amendment to Facility Agreement, Senior Secured Convertible Notes and Warrants, dated as of December 17, 2019, by and among KemPharm, Inc.,... (Filed With SEC on December 18, 2019)

Amended and Restated Senior Secured Convertible Note issued to Deerfield Private Design Fund III, L.P., dated as of December 18, 2019 (Filed With SEC on December 18, 2019)

Amended and Restated Guaranty and Security Agreement, dated as of December 18, 2019, by and among KemPharm, Inc., each other Grantor party thereto, each Guarantor party thereto... (Filed With SEC on December 18, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 30, 2019 (Filed With SEC on November 14, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 16, 2019 (Filed With SEC on November 14, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 23, 2019 (Filed With SEC on November 14, 2019)

Fourth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 14, 2019)

Agreement to Terminate CLA, by and between MonoSol Rx, LLC and the Registrant, dated as of March 20, 2012 (Filed With SEC on November 14, 2019)

Collaboration and License Agreement, dated as of September 3, 2019, by and between KemPharm, Inc. and Boston Pharmaceuticals Holdings SA (Filed With SEC on September 4, 2019)

September 2019 Exchange Agreement and Amendment to Facility Agreement, dated as of September 3, 2019, by and among KemPharm, Inc., Deerfield Private Design Fund III, L.P. and... (Filed With SEC on September 4, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 9, 2019 (Filed With SEC on August 13, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated July 31, 2019 (Filed With SEC on August 13, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated July 15, 2019 (Filed With SEC on August 13, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 28, 2019 (Filed With SEC on August 13, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 24, 2019 (Filed With SEC on August 13, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 17, 2019 (Filed With SEC on August 13, 2019)

Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 3, 2019 (Filed With SEC on August 13, 2019)

Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2014 Equity Incentive Plan (Filed With SEC on May 14, 2019)

Amended Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2019)

Warrant to Purchase Shares of Common Stock issued to KVK Tech, Inc. dated October 25, 2018 (Filed With SEC on March 1, 2019)

Collaboration and License Agreement by and between the Company and KVK Tech, Inc. dated as of October 25, 2018 (Filed With SEC on March 1, 2019)

Purchase Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 1, 2019)

Seventh Amendment to Senior Secured Convertible Note and Sixth Amendment to Warrant, dated February 28, 2019, between the Company and Deerfield Private Design Fund III, L.P (Filed With SEC on March 1, 2019)

Registration Rights Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 1, 2019)

KEMPHARM, INC (68)